These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12353815)

  • 1. Changing incidence of lobular carcinoma in situ of the breast.
    Li CI; Anderson BO; Daling JR; Moe RE
    Breast Cancer Res Treat; 2002 Oct; 75(3):259-68. PubMed ID: 12353815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
    Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
    Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.
    Page DL; Kidd TE; Dupont WD; Simpson JF; Rogers LW
    Hum Pathol; 1991 Dec; 22(12):1232-9. PubMed ID: 1748429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA; King TA
    Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
    Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
    King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
    J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
    Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular carcinoma in situ and invasive cancer: the contralateral breast controversy.
    Carolin KA; Tekyi-Mensah S; Pass HA
    Breast J; 2002; 8(5):263-8. PubMed ID: 12199752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
    Portschy PR; Marmor S; Nzara R; Virnig BA; Tuttle TM
    Ann Surg Oncol; 2013 Oct; 20(10):3240-6. PubMed ID: 23846782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.